These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 15830478)
21. Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019. Forbes JD; Kus JV; Patel SN Anaerobe; 2021 Aug; 70():102386. PubMed ID: 34044100 [TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90. Henderson G; Garner J; Morris A N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266 [TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria]. Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621 [TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital. Tan TY; Ng LS; Kwang LL; Rao S; Eng LC Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial therapy of postpartum endomyometritis. I. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria. Sorrell TC; Marshall JR; Chow AW Am J Obstet Gynecol; 1981 Oct; 141(3):242-5. PubMed ID: 6456667 [TBL] [Abstract][Full Text] [Related]
26. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)]. Tytgat F Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739 [TBL] [Abstract][Full Text] [Related]
27. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan. Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668 [TBL] [Abstract][Full Text] [Related]
28. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities]. Doğan M; Baysal B Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955 [TBL] [Abstract][Full Text] [Related]
29. Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008-2012, northern Taiwan. Wang FD; Liao CH; Lin YT; Sheng WH; Hsueh PR Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):2041-52. PubMed ID: 24930042 [TBL] [Abstract][Full Text] [Related]
30. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species. Byun JH; Kim M; Lee Y; Lee K; Chong Y Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782 [TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model. Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626 [TBL] [Abstract][Full Text] [Related]
32. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics. Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. Sutter VL; Finegold SM J Infect Dis; 1975 Apr; 131(4):417-22. PubMed ID: 804023 [TBL] [Abstract][Full Text] [Related]
34. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria. Nord CE; Lindmark A; Persson I Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):784-6. PubMed ID: 7802861 [TBL] [Abstract][Full Text] [Related]
35. In-vitro antibiotic susceptibility and molecular analysis of anaerobic bacteria isolated in Cape Town, South Africa. Koch CL; Derby P; Abratt VR J Antimicrob Chemother; 1998 Aug; 42(2):245-8. PubMed ID: 9738844 [TBL] [Abstract][Full Text] [Related]
37. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. Goldstein EJ; Citron DM; Cherubin CE; Hillier SL J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570 [TBL] [Abstract][Full Text] [Related]
38. Susceptibility of anaerobic bacteria in Auckland: 1991-1996. Shore KP; Pottumarthy S; Morris AJ N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections. Hill GB; Ayers OM Antimicrob Agents Chemother; 1985 Mar; 27(3):324-31. PubMed ID: 3994347 [TBL] [Abstract][Full Text] [Related]
40. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg. van der Westhuyzen I; Chalkley LJ S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]